Evotec SE (EVO) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Evotec Se.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.267 -- 00:00:02.267 Ladies 00:00:02.269 -- 00:00:08.055 and gentlemen, welcome to the Evotech SE half-year report 2025 conference 00:00:08.055 -- 00:00:10.598 call. I am Mathilde, the chorus call operator. 00:00:10.598 -- 00:00:15.263 I would like to remind you that all participants will be in listen-only mode and the 00:00:15.263 -- 00:00:20.529 conference is being recorded. The presentation will be followed by a Q&A session. 00:00:20.529 -- 00:00:25.715 You can register for questions at any time by pressing star and 1 on your telephone. 00:00:25.715 -- 00:00:29.258 For operator assistance, please press star and 0. 00:00:29.258 -- 00:00:34.485 The conference must not be recorded for publication or broadcast. 00:00:34.485 -- 00:00:39.591 At this time, it's my pleasure to hand over to Volker Braun, head of IR and 00:00:39.591 -- 00:00:42.755 ESG. Please go ahead. 00:00:42.755 -- 00:00:46.821 Thank you, Matilda, and good morning, good afternoon to everyone in the call. 00:00:46.821 -- 00:00:51.907 Thank you for joining us today. Today, we will cover our first half 2025 00:00:51.907 -- 00:00:56.782 results, and we will discuss the progress we have made in the execution of our strategy 00:00:56.782 -- 00:01:00.325 as well as the key operational and external developments. 00:01:00.325 -- 00:01:04.709 We will, of course, also provide an update on the evolution of the Just Evotate Biologics 00:01:04.709 -- 00:01:07.951 business, of which the plant Sandoz deal is part of. 00:01:07.951 -- 00:01:12.635 However, because of the running process, we will not dwell in the details as such. 00:01:12.635 -- 00:01:15.258 We appreciate your understanding. 00:01:15.258 -- 00:01:19.481 Before we start, the usual 30 seconds on housekeeping items. 00:01:19.481 -- 00:01:22.72...